Skip to main content

Nationwide molecular surveillance of three Plasmodium species harboured by symptomatic malaria patients living in Ghana



Clinical presentations of malaria in Ghana are primarily caused by infections containing microscopic densities of Plasmodium falciparum, with a minor contribution from Plasmodium malariae and Plasmodium ovale. However, infections containing submicroscopic parasite densities can result in clinical disease. In this study, we used PCR to determine the prevalence of three human malaria parasite species harboured by suspected malaria patients attending healthcare facilities across the country.


Archived dried blood spots on filter paper that had been prepared from whole blood collected from 5260 patients with suspected malaria attending healthcare facilities across the country in 2018 were used as experimental material. Plasmodium species-specific PCR was performed on DNA extracted from the dried blood spots. Demographic data and microscopy data for the subset of samples tested were available from the original study on these specimens.


The overall frequency of P. falciparum, P. malariae and P. ovale detected by PCR was 74.9, 1.4 and 0.9%, respectively. Of the suspected symptomatic P. falciparum malaria cases, 33.5% contained submicroscopic densities of parasites. For all regions, molecular diagnosis of P. falciparum, P. malariae and P. ovale was significantly higher than diagnosis using microscopy: up to 98.7% (75/76) of P. malariae and 97.8% (45/46) of P. ovale infections detected by PCR were missed by microscopy.


Plasmodium malariae and P. ovale contributed to clinical malaria infections, with children aged between 5 and 15 years harbouring a higher frequency of P. falciparum and P. ovale, whilst P. malariae was more predominant in individuals aged between 10 and 20 years. More sensitive point-of-care tools are needed to detect the presence of low-density (submicroscopic) Plasmodium infections, which may be responsible for symptomatic infections.

Graphical Abstract


Plasmodium species that infect humans include Plasmodium malariae, Plasmodium ovale, Plasmodium vivaxPlasmodium knowlesi, and Plasmodium falciparum; of these  P. falciparum is responsible for most of the malaria cases in Ghana [1, 2]. In Ghana, low-level infections caused by P. malariae and P. ovale have been reported, but these species are predominantly present as mixed infections with P. falciparum [3, 4] and also as low-density infections.

Infections with all human Plasmodium parasites can result in various presentations of disease, with the uncomplicated and asymptomatic presentations being the most predominant manifestations of parasite infection. Uncomplicated malaria often presents with fever, chills, profuse sweating, headache, vomiting and diarrhoea [2], whilst asymptomatic infections are devoid of apparent physical symptoms of the disease. Some infections, however, do result in severe disease, whose presentations include severe anaemia and end-organ damage such as cerebral malaria, pulmonary complications and hypoglycaemia [5].

Microscopy is the gold standard for Plasmodium parasite detection, especially for clinical cases of malaria as these usually contain high densities of parasites [6, 7]. Microscopy can provide an estimate of malaria parasite density from thick blood smears and information on the various parasite species present in an infection from a thin blood smear. The downside to microscopy is that it requires experts to prepare and stain the blood smear as well as electricity and a microscope, in addition to an expert malaria microscopist to read and grade the smear.

Accurate estimation of the density of the infecting parasites and accurate identification of the infecting parasite species are two properties of infection that are essential to the proper management of malaria, including providing information on the appropriate drug treatment [8, 9]. In malaria endemic areas where P. falciparum is predominant and widespread, P. malariae, and P. ovale infections are usually underdiagnosed, with almost all clinical malaria cases attributed to P. falciparum infection [10, 11]. Some factors that have been associated with underdiagnosing non-falciparum malaria by microscopy in P. falciparum malaria endemic countries include: (i) the very low parasitaemia of P. malariae and P. ovale; and (ii) the lack of highly skilled microscopists who can distinguish the different Plasmodium species [12,13,14]. Molecular tools, including various forms of nucleic acid amplification tests, such as conventional and real-time PCR, can provide accurate estimates of parasite density and accurate identification of the infecting parasite species. PCR methodology is not a point-of-care diagnostic tool and is typically reserved for research in malaria-endemic countries; however, it is regarded as the new gold standard in cases of low parasitemia and mixed-species infections [5]. The sensitivity and selectivity of PCR methods are superior to those of microscopy and rapid diagnostic tests, with the detection limit of nested PCR set at as low as 0.2 parasite/µl [15].

Ghana is a malaria mesoendemic country which still has some facilities to confirm the suspicion of malaria in patients suspected of having this disease (symptomatic individuals) with microscopy. The aim of this study was to use PCR to determine the frequency and distribution of the three common malaria parasite species in patients with suspected malaria who were seeking treatment in 100 different healthcare facilities across Ghana in 2018.


Study population

Convenience sampling was used to select between 292 and 600 archived dried blood spots on filter paper from a pool of about 2000 such samples that had been collected in the original study from patients with suspected malaria attending clinics in the 10 regions of Ghana. The adoption of convenience sampling limited the data for analysis to the selected samples, with the inherent possibility of under-/over-representation of the original study population. The selection criterion for the samples was any dried blood spot on filter paper for which there was sufficient material to punch out two 3-mm-radius spots for analysis. The samples used originated from samples taken from 5260 individuals who had been recruited as part of a larger study that enrolled 19,787 patients with suspected symptomatic malaria. Patients for this larger study were recruited from 100 healthcare facilities (10 from each of the then 10 regions of the country). Study participants ranged in age from 1 to 94 years. The demographics of the larger study population have been reported previously [16, 17].

Study site

This cross-sectional study was conducted in the 10 regions of Ghana as of 2018: Greater Accra Region (GAR), Central Region (CR), Ashanti Region (AR), Western Region (WR), Eastern Region (ER), Brong-Ahafo Region (BAR), Volta Region (VR), Northern Region (NR), Upper East Region (UER) and Upper West Region (UWR). Ten healthare facilities were randomly selected in each of the 10 regions of Ghana [16, 17].

Sample collection and processing

The samples used in this study were collected between May and August 2018 as described earlier [16, 17]. Demographic data were obtained from each consenting participant, and about 2 ml of venous blood was collected into an EDTA-vacutainer® tube. Thick and thin blood smears were prepared and processed for malaria parasite identification and quantification as previously described [2]. Dried blood spots on filter paper were prepared by spotting four 50-µl drops of the venous blood onto a Whatman® No. 3 filter paper (Whatman plc, Maidstone, UK), following which the blood spots were air-dried and stored individually in zip-lock bags containing silica gels. Packed cells were then isolated from the remaining venous blood and stored in a 1.5-ml Eppendorf tube at − 20 °C for future use [16].


Each thick and thin blood smear obtained from the original study was read by two independent WHO-certified malaria microscopists; any disagreement on smear readings was resolved by re-examination and assessment by a third microscopist. The assessment by the third microscopists was considered to be the final decision [16, 17].

DNA extraction

Genomic DNA was extracted from the dry blood spots (DBS) using the Chelex extraction method [18, 19] with few modifications. Each punched-out DBS was placed into a sterile 1.5-ml microfuge tube containing 1 ml of 1× phosphate-buffered saline (PBS) supplemented with Tween-20 solution (0.5% PBST). The tubes were incubated overnight at room temperature with intermittent shaking, then centrifuged for 2 min at 21,000 g and the reddish supernatant decanted. The DBS punches were then washed in ice-cold PBS at 4 °C for 30 min and the supernatant again discarded. Finally, 50 μl of freshly prepared 20% Chelex-100 in distilled water and 100 μl of distilled water were added to each tube. The tubes were then heated at 95 °C for 10 min, with repeated vortexing at 2-min intervals. The tubes containing the extracted DNA were finally centrifuged at 21,000 g for 8 min, and the supernatant containing the DNA was transferred into a new sterile tube and stored at – 20 °C until use.

Nested PCR

Plasmodium species (P. falciparum, P. malariae, and P. ovale) identification

The 18S ribosomal RNA gene, a conserved region in P. falciparum, P. malariae and P. ovale, was amplified using nested PCR from genomic DNA using a protocol described previously [2], with minor modifications. In the primary reaction (nest 1), 250 nM of the genus-specific primers rPLU1 (forward) and rPLU5 (reverse) were used in a total reaction volume of 10 μl consisting of of 2 μl DNA template, 1× PCR buffer, 200 nM dNTPs, 700 nM MgCl2 and 1 U of OneTaq DNA polymerase. In the secondary reaction (nest 2), the species-specific primers rFAL1/rFAL2 (200 nM), rMAL1/ rMAL2 (200 nM) and rOVA1/rOVA2 (200 nM) were used in separate 10-μl reactions using 0.5 μl of the primary reaction product as a template for the identification of P. falciparum, P. malariae and P. ovale, respectively. The primary and secondary reactions were run at an initial denaturation temperature of 94 °C for 2 min; this was followed by a second denaturation at 94 °C for 30 s, primer annealing at 55 °C (for initial reaction) and 58 °C (for the second reaction), both for 30 s, and extension at 68 °C for 1 min 30 s for nest 1, 30 s for nest 2 (P. falciparum, P. malariae) and 1 min for P. ovale (nest 2); and a final extension at 68 °C for 5 min. Positive control samples used for this study included known P. falciparum and P. ovale or P. malariae DNA samples that had been obtained as part of the Distribution 4881 of the WHO Malaria NAAT EQA programme; ultra-pure water was used as a negative control. The nest 2 PCR products were resolved in a 2% agarose gel pre-stained with ethidium bromide. The gels were subsequently visualised using the UV settings on the Vilber gel documentation system (Vilber, Collégien, France).

Statistical analysis

All data acquired during this study were entered into Microsoft Excel (Microsoft Corp., Redmond, WA, USA), and the statistical analyses were performed with GraphPad Prism software, version 8.4.3 (GraphPad Software, San Diego, CA, USA). The data were grouped according to regions, diagnostic tests, gender and age categories. The frequency of malaria species was determined using simple counts and proportions. The associations between frequency of species and explanatory variables were determined using chi-square statistics. Statistical significance was set at P < 0.05.


Demographic characteristics of study subjects

The distribution of three different Plasmodium species in the 10 regions of the country was assessed in all dried blood spot punches from 5260 study subjects with suspected malaria. The mean age ± standard error of the mean of these subjects in the study year (2018) ranged from 14.2 ± 0.7 (95% confidence interval [CI]: 12.8–15.5) in the Brong Ahafo region to 27.2 ± 0.9 (95% CI: 25.5–29.0) in the Upper West region of Ghana. Female participants slightly outnumbered male ones across all regions; the Central region had the highest proportion of female participants (62.9%) (Table 1).

Table 1 Demographic characteristics of the study subjects according to region of Ghana

Regional distribution of Plasmodium species among study subjects


The frequency of P. falciparum detected by microscopy in the subset of samples used in this study was 2284/4937 (46.3%), with the highest frequency identified in the Ashanti region 412/476 (86.6%) and the lowest detected in the Eastern region 41/292 (14.0%) (Table 1). Microscopy identified one P. malariae and one P. ovale infection, which were both observed in the Ashanti region. A few samples (323/5260, 6.1%) were missing microscopy data.


Overall, PCR detected P. falciparum in 3942 of the 5260 (74.9%) individuals sampled, with the highest frequency identified in the Ashanti region (497/519, 95.8%) and lowest detected in the Upper West region (304/655, 46.4%) (Fig. 1a; Table 1). There was a significant difference in the frequency of P. falciparum detected by PCR compared to microscopy in all the regions of Ghana (χ2 = 215.24, df = 1, P < 0.0001) (Table 2).

Fig. 1
figure 1

The prevalence of Plasmodium falciparum and non-falciparum parasites in 10 regions of Ghana. a Regional prevalence of P. falciparum detected by PCR in Ghana. b Prevalence of non-falciparum malaria (Plasmodium malariae and Plasmodium ovale) detected by PCR across the 10 regions of Ghana. c Bar graph showing the prevalence of mixed Plasmodium infections in Ghana. Abbreviations (a, b): AR, Ashanti region; BAR, Brong Ahafo region; CR, Central region; ER, Eastern region; GAR, Greater Accra region; NR, Northern region; UER, Upper East region; UWR, Upper West region; VR, Volta region; WR, Western region. Abbreviations (c): Pf, Plasmodium falciparum; Pm, Plasmodium malariae; Po, Plasmodium ovale

Table 2 Chi-square statistics comparing the prevalence of Plasmodium species by PCR and microscopy at each of the 10 regions of Ghana

The overall frequency of non-falciparum malaria (P. malariae and P. ovale) detected by PCR was 122/5260 (2.3%), with P. malariae accounting for 76 of the 122 (62.3%) samples PCR-positive for non-falciparum malaria. The frequency of P. malariae was highest in the Ashanti region (15/519, 3.0%) and lowest in the Western region (6/484, 1.2%), with no P. malariae infection detected in the Greater Accra region. The frequency of P. ovale ranged from 2/655 (0.3%) in the Upper West region to 13/563 (2.3%) in the Brong Ahafo region (Fig. 1b).

Mixed species infections

The majority (109/122, 89.3%) of the non-falciparum malaria infections detected by PCR were detected as mixed infections. The overall frequency of P. falciparum–P. malariae (PfPm), P. falciparum–P. ovale (PfPo), P. malariae–P. ovale (PmPo) and P. falciparum–P. malariae–P. ovale (PfPmPo) mixed infections were 64/109 (58.7%), 42/109 (38.5%), 1/109 (0.9%) and 2/109 (1.8%) respectively.

The only case of infection that contained all three parasite species was observed in the Ashanti region, and the only case of PmPo mixed infection was observed in the Western region of Ghana. The highest frequency of PfPo infection was observed in the Brong Ahafo region (13/42, 31%) and the lowest in the Western region (1/42, 2.4%). The frequency of PfPm mixed infection was high in the Volta (13/64, 20.3%), Ashanti (12/64, 18.8%), Brong Ahafo (12/64, 18.8%), Central (10/64 (15.6%) and Northern (8/64, 12.5%) regions. The mean frequency of PfPm mixed infections and PmPo mixed infections across the 10 regions of Ghana were 6.4 ± 1.6 and 4.20 ± 1.2, respectively (Fig. 1c). There was a significant difference in P. malariae and P. ovale malaria diagnosis by PCR compared to microscopic diagnosis in the Ashanti (χ2 = 11.27, df = 1, P = 0.0008 and χ2 = 7.6, df = 1, P  = 0.0058, respectively) and Brong Ahafo (χ2 = 15.2, df = 1, P < 0.0001 and χ2 = 13.15, df = 1, P = 0.0003, respectively) regions, where these parasites were identified (Table 2).

Submicroscopic infections (PCR-positive but microscopy-negative)

The PCR estimates of P. falciparum (χ2 = 258.6, df = 1, P < 0.0001), P. malariae (χ2 = 709.4, df = 1, P < 0.0001) and  P. ovale (χ2 = 424.5, df = 1, P < 0.0001) were significantly higher than the microscopy estimates across all the regions. A total of 33.8% (1776/5260) of the symptomatic P. falciparum malaria infections were submicroscopic. The Ashanti region contributed the least to the overall number of individuals with submicroscopic infections (85/1776, 17.1%).

The majority (75/120, 63.3%) of submicroscopic non-falciparum infections were caused by P. malariae (Table 1). Submicroscopic infections accounted for 100% of the non-falciparum infections detected in all regions except for the Ashanti region where submicroscopic P. malariae and P. ovale accounted for 14/15 (93.3%) and 10/11 (90.9%), respectively, of the total non-falciparum infections identified in those regions (Table 1).

Distribution of malaria parasite frequency by PCR in the 10 regions of Ghana by age and gender

The overall frequency of P. falciparum detected by PCR (Pf-PCR) among the age categories 0–4, 5–9, 10–15, 16–20 and > 20 years were 719/867 (82.9%), 987/1145 (86.2%), 591/700 (84.4%), 430/547 (78.6%) and 1135/1862 (61%), respectively. The Greater Accra and Eastern regions had the lowest Pf-PCR positivity rate among individuals aged 0–4 years (26/719, 3.6% and 23/719, 3.2%, respectively). The highest Pf-PCR positivity rate in individuals aged 0–4 years was identified in the Brong Ahafo region (150/719, 20.9%). There was a significantly lower frequency of malaria in individuals aged 10–15 years and 16–20 years compared to individuals aged 0–4 years (χ2 = 5.185, df = 1, P = 0.0228 and χ2 = 81.13, df = 1, P < 0.0001, respectively). However, individuals aged between 5 and 9 years had a higher frequency of malaria compared to individuals aged 0–4 years (χ2 = 20.48, df = 1, P < 0.0001 (Fig. 2a).

Fig. 2
figure 2

Regional distribution of Plasmodium species among age-stratified categories (< 5, 5–9, 10–15, 16–20 and > 20 years). a Regional distribution of P. falciparum in percentage across the age categories among the study subjects. b Regional distribution of P. malariae in percentage across the age categories among the study subjects. c Regional distribution of P. ovale in percentage across the age categories among the study subjects

The overall frequency of P. malariae among the age group 10–15 years was 2.9% (20/700), with individuals from the Brong Ahafo region contributing the most in absolute numbers (6/20, 30%) within this age group. A total of 9.0% (6/67) of individuals in the age group 10–15 years from the Brong Ahafo region were infected with P. malariae. The frequency of P. malariae in individuals belonging to the age groups 16–20 years and > 20 years were highest in the Ashanti and Brong Ahafo regions (Fig. 2b).

A total of nine individuals aged 0–4 years were infected with P. ovale, with individuals from the Brong Ahafo region contributing the most (4/9, 44.4%) within this age group. In the Ashanti region, of the 88 individuals infected with P. ovale, three (3.4%) were aged 0–4 years.

A total of 13 individuals in the age group 10–15 years were infected with P. ovale, with individuals from the Brong Ahafo Region contributing the most (4/13, 30.8%) within this age group. Of the 86 individuals from the Ashanti Region aged between 10 and 15 years, four (4.7%) were infected with P. ovale (Fig. 2c).

Overall, there was a significant difference (χ2 = 33.702, df = 1, P < 0.0001) in the frequency of P. falciparum infections in male subjects (1667/2100, 79.4%) compared to female subjects (2195/3021, 72.7%). Male subjects had a relatively higher frequency of P. falciparum infections compared to their female counterparts across all the regions, with the exception of the Eastern region where PCR identified 80.7% (n = 134) of the overall female participants and 79.5% (n = 97) of the overall total male participants to be infected with P. falciparum.

Plasmodium malariae detected by PCR was identified in 46/3021 (1.5%) and 30/2100 (1.4%) of the female and male participants, respectively. The frequency of P. malariae was significantly higher (χ2 = 42.039, df = 1, P < 0.0001) among female participants than among male participants in all regions, except for the Eastern and Volta regions (Fig. 3b).

Fig. 3
figure 3

The distribution of Plasmodium species in male and female study participants in the 10 regions of Ghana. a Prevalence of P. falciparum infection among the male and female study subjects across the 10 regions of Ghana. b Pevalence of P. malariae infection among the male and female study subjects across the 10 regions of Ghana. c Prevalence of P. ovale infection among the male and female study subjects across the 10 regions of Ghana

Overall, P. ovale was identified in 29/3021 (1.0%) and 17/2100 (0.8%) of female and male participants, respectively. Infections containing P. ovale were detected in only four regions. The frequency of P. ovale in the Ashanti region was similar between male (5/222, 2.3%) and female (6/286 (2.1%) participants. In the Brong Ahafo region, P. ovale was more prevalent in female (10/319, 3.1%) than males (3/241, 1.2%) participants. In the Eastern region, P. ovale was identified in 2/166 (1%) female subjects; in the Upper West region, 4/171 (2.3%) male subjects were identified with P. ovale (Fig. 3c).


Globally, recent years has seen a substantial reduction in clinical malaria incidence, morbidity and mortality [20, 21]. However, this achievement could be hindered by the presence of submicroscopic densities of Plasmodium, especially those that result in clinical disease. In Ghana, three main Plasmodium species cause malaria, namely P. falciparum, P. malariae and P. ovale [3, 22], and the main diagnostic tools used to identify malaria among symptomatic malaria patients are microscopy and HRP2 (histidine-rich protein 2)-based malaria RDT (rapid diagnostic test) kits. Our previous molecular studies on the composition of Plasmodium infections, including our study on school children in the Central region of Ghana and the community-based study in the Eastern region, focused predominantly on asymptomatic individuals [3, 22]. In the present study, we used PCR to determine the frequency of Plasmodium infections amongst suspected symptomatic malaria patients and identified patients with suspected malaria whose infection was missed by the routine point-of-care tool due to low parasite densities and also to HRP2 deletions since many RDTs are HRP2-based tests.

Although there has been a substantial reduction in malaria prevalence and mortality, there are reports of a high malaria burden in older children [23]. The present study identified a high frequency of P. falciparum and P. ovale in individuals aged between 5 and 15 years and an increased frequency of P. malariae in individuals aged between 10 and 20 years. The shift in malaria prevalence from younger children to older children could be due to the implementation of numerous malaria control interventions that have targeted vulnerable populations [24, 25]. In the present study, children aged < 5 years, an age group known to be the most risk of developing malaria [26, 27], did not have the highest frequency of malaria parasites. This finding suggests that the malaria control interventions which have been implemented for children aged < 5 years old are very effective and should be scaled up to include the entire population, starting with children aged 5–10 years who presented with the highest frequency of PCR-detectable malaria parasites in the present study. The results of this study also showed that the frequencies of P. malariae and P. ovale causing symptomatic disease are very similar to those reported previously from other countries in sub-Saharan Africa, where 0.2–4.8% P. ovale malaria cases and 0.3–2.8% of P. malariae malaria cases were associated with symptomatic malaria [14, 28,29,30,31,32,33].

While malaria affects both males and females [34, 35], gender was identified as a factor that influenced the vulnerability to malaria infection. The present study showed that males were significantly more likely to harbour a P. falciparum infection than female subjects, which could be the result of differences in exposure patterns between males and females. Males between the age of 5 and 15 years were more likely to have a greater risk of exposure to mosquito bites as they may stay longer outside without protection and be less likely to sleep under insecticide-treated bed nets [36]. From a public health perspective, the 7% difference in P. falciparum frequency between males and females may not influence the implementation of malaria control measures between males and females. However, it is worth noting as malaria parasite frequency in malaria-endemic communities is dynamic.

The frequency of P. malariae frequency identified in this study is similar to that reported previously from two regions of Ghana [37, 38]. Although the frequency of P. malariae was low, a large number of samples analysed provides the high statistical power to conclude the outcomes. The increased vulnerability of females to P. malariae is unknown; however, a similar observation was identified among females living in Orissa [37]. One possible explanation is that P. malariae is spread by indoor biting vectors and females have a higher exposure to indoor biting vectors [38, 39].

Point-of-care tools, including microscopy and malaria RDT kits, are required for malaria diagnosis to ensure that rapid and effective treatment can be provided. However, the sensitivity of these tools reduces significantly with decreasing parasite density of the infection [40]. The nested PCR assay used in this study identified a large proportion of malaria infections that were not detected by either or both microscopy and the malaria RDT and which remained either misdiagnosed or undiagnosed, similar to the previous reports from Cameroon [3, 40]. Submicroscopic malaria parasites among febrile patients have been enumerated; however, due to overlapping symptoms between malaria and other febrile diseases, highly sensitive POC diagnostic tests must be used for diagnosis [40]. Although submicroscopic malaria infections rarely cause clinical disease, in some cases severe and acute symptoms, such as mild anaemia, coughing, vomiting and jaundice, may develop as the disease progresses without appropriate treatment [41]. Early detection of submicroscopic malaria parasites is very important as it ensures appropriate treatment and the accurate determination of the malaria reservoir size [42, 43]. When submicroscopic malaria parasite infections are not detected and treated, they contribute to the maintenance of disease transmission as these infections frequently harbour gametocytes [44, 45].

The use of convenience sampling to obtain the samples for this study resulted in a bias, which caused the overall frequency of Plasmodium infections detected by microscopy (46.3%) in the subset of suspected malaria patients used in this study to be higher than that reported in the original larger study (16%) [17]. However, the focus of this study was not on determining the overall parasite prevalence per se but rather on the regional distribution of the various Plasmodium species and on highlighting the higher sensitivity of PCR at detecting malaria parasite infections, especially the non-falciparum species, amongst patients with suspected malaria attending healthcare facilities.


Plasmodium malariae and P. ovale as mono-infections resulted in symptomatic malaria cases. Plasmodium falciparum and P. ovale were more commonly detected in children aged between 5 and 15 years, whilst P. malariae was more prevalent in individuals aged between 10 and 20 years. Male subjects had a higher frequency of P. falciparum infection than female subjects, whilst P. malariae was more prevalent in female subjects. More sensitive point-of-care tools are needed to detect the presence of low-density (submicroscopic) Plasmodium infections, which can result in symptomatic infections (Additional file 1).

Availability of data and materials

All data generated or analysed during this study are included in this published article.


  1. World Health Organization (WHO). World malaria report 2020: 20 years of global progress and challenges. 2020. Accessed 2 Jan 2021.

  2. Crawley J, Chu C, Mtove G, Nosten F. Malaria in children. Lancet. 2010;375:1468–81.

    Article  PubMed  Google Scholar 

  3. Amoah LE, Donu D, Abuaku B, Ahorlu C, Arhinful D, Afari E, et al. Probing the composition of Plasmodium species contained in malaria infections in the Eastern region of Ghana. BMC Public Health. 2019;19:1617.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Awine T, Malm K, Bart-Plange C, Silal SP. Towards malaria control and elimination in Ghana: challenges and decision-making tools to guide planning. Glob Health Action. 2017;10:1381471.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Amir A, Cheong FW, De Silva JR, Lau YL. Diagnostic tools in childhood malaria. Parasit Vectors. 2018;11:53.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Iwuafor AA, Ita OI, Ogban GI, Udoh UA, Amajor CA. Evaluation of diagnostic accuracy of rapid diagnostic test for malaria diagnosis among febrile children in Calabar, Nigeria. Niger Med J. 2018;59:64–9.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Berzosa P, de Lucio A, Romay-Barja M, Herrador Z, González V, García L, et al. Comparison of three diagnostic methods (microscopy, RDT, and PCR) for the detection of malaria parasites in representative samples from Equatorial Guinea. Malar J. 2018;17:333.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Loick Pradel KF, Pande V, Singh V. Field performances of rapid diagnostic tests detecting human Plasmodium species: a systematic review and meta-analysis in India, 1990–2020. Diagnostics. 2021;11:590.

    Article  Google Scholar 

  9. Jiram AI, Ooi CH, Rubio JM, Hisam S, Karnan G, Sukor NM, et al. Evidence of asymptomatic submicroscopic malaria in low transmission areas in Belaga district, Kapit division, Sarawak, Malaysia. Malar J. 2019;18:156.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Imbert P, Rapp C, Buffet PA. Pathological rupture of the spleen in malaria: analysis of 55 cases (1958–2008). Travel Med Infect Dis. 2009;7:147–59.

    Article  PubMed  Google Scholar 

  11. Haanshuus CG, Mørch K, Blomberg B, Strøm GE, Langeland N, Hanevik K, et al. Assessment of malaria real-time PCR methods and application with focus on low-level parasitaemia. PLoS ONE. 2019;14:e0218982.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Heinemann M, Phillips RO, Vinnemeier CD, Rolling CC, Tannich E, Rolling T. High prevalence of asymptomatic malaria infections in adults, Ashanti Region, Ghana, 2018. Malar J. 2020;19:366.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Cao Y, Wang W, Liu Y, Cotter C, Zhou H, Zhu G, et al. The increasing importance of Plasmodium ovale and Plasmodium malariae in a malaria elimination setting: an observational study of imported cases in Jiangsu Province, China, 2011–2014. Malar J. 2016;15:459.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kotepui M, Kotepui KU, Milanez GD, Masangkay FR. Severity and mortality of severe Plasmodium ovale infection: a systematic review and meta-analysis. PLoS ONE. 2020;15:e0235014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Li P, Zhao Z, Wang Y, Xing H, Parker DM, Yang Z, et al. Nested PCR detection of malaria directly using blood filter paper samples from epidemiological surveys. Malar J. 2014;13:175.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Amoah LE, Abuaku B, Bukari AH, Dickson D, Amoako EO, Asumah G, et al. Contribution of P falciparum parasites with Pfhrp 2 gene deletions to false negative PfHRP 2 based malaria RDT results in Ghana: a nationwide study of symptomatic malaria patients. PLoS ONE. 2020;15:e0238749.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Abuaku B, Amoah LE, Peprah NY, Asamoah A, Amoako EO, Donu D, et al. Malaria parasitaemia and mRDT diagnostic performances among symptomatic individuals in selected health care facilities across Ghana. BMC Public Health. 2021;21:239.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Amoah LE, Opong A, Ayanful-Torgby R, Abankwa J, Acquah FK. Prevalence of G6PD deficiency and Plasmodium falciparum parasites in asymptomatic school children living in southern Ghana. Malar J. 2016;15:388.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Obboh EK, Okonu RE, Amoah LE. Large variations in malaria parasite carriage by afebrile school children living in nearby communities in the central region of Ghana. J Trop Med. 2020;2020:4125109.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Weiss DJ, Lucas TC, Nguyen M, Nandi AK, Bisanzio D, Battle KE, et al. Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study. Lancet. 2019;394:322–31.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Battle KE, Lucas TC, Nguyen M, Howes RE, Nandi AK, Twohig KA, et al. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study. Lancet. 2019;394:332–43.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bredu D, Donu D, Amoah LE. Dynamics of the composition of Plasmodium species contained within asymptomatic malaria infections in the central region of Ghana. J Trop Med. 2021;2021:7419548.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Griffin JT, Ferguson NM, Ghani AC. Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa. Nat Commun. 2014;5:3136.

    Article  PubMed  Google Scholar 

  24. Azabre BA, Teye JK, Yaro JA. Malaria control strategies in the Kassena-Nankana east and west districts of Ghana. Ghana J Geography. 2013;5:102–20.

    Google Scholar 

  25. Monroe A, Asamoah O, Lam Y, Koenker H, Psychas P, Lynch M, et al. Outdoor-sleeping and other night-time activities in northern Ghana: implications for residual transmission and malaria prevention. Malar J. 2015;14:35.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Winskill P, Walker PG, Cibulskis RE, Ghani AC. Prioritizing the scale-up of interventions for malaria control and elimination. Malar J. 2019;18:122.

    Article  PubMed  PubMed Central  Google Scholar 

  27. World Health Organization (WHO). Achieving and maintaining universal coverage with long-lasting insecticidal nets for malaria control. 2017. Accessed 7 Mar 2021.

  28. Yman V, Wandell G, Mutemi DD, Miglar A, Asghar M, Hammar U, et al. Persistent transmission of Plasmodium malariae and Plasmodium ovale species in an area of declining Plasmodium falciparum transmission in eastern Tanzania. PLoS Negl Trop Dis. 2019;13:e0007414.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Akala HM, Watson OJ, Mitei KK, Juma DW, Verity R, Ingasia LA, et al. Plasmodium interspecies interactions during a period of increasing prevalence of Plasmodium ovale in symptomatic individuals seeking treatment: an observational study. Lancet Microbe. 2021;2:e141–50.

    Article  CAS  Google Scholar 

  30. Djallé D, Gody JC, Moyen JM, Tekpa G, Ipero J, Madji N, et al. Performance of Paracheck™-Pf, SD Bioline malaria Ag-Pf and SD Bioline malaria Ag-Pf/pan for diagnosis of falciparum malaria in the Central African Republic. BMC Infect Dis. 2014;14:109.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Culleton RL, Mita T, Ndounga M, Unger H, Cravo PV, Paganotti GM, et al. Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Malar J. 2008;7:174.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Langford S, Douglas NM, Lampah DA, Simpson JA, Kenangalem E, Sugiarto P, et al. Plasmodium malariae infection associated with a high burden of anemia: a hospital-based surveillance study. PLoS Negl Trop Dis. 2015;9:e0004195.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Ricci F. Social implications of malaria and their relationships with poverty. Mediterr J Hematol. 2012;4:e2012048.

    Article  Google Scholar 

  34. Pell C, Straus L, Andrew EV, Meñaca A, Pool R. Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS ONE. 2011;6:e22452.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Njatosoa AF, Mattern C, Pourette D, Kesteman T, Rakotomanana E, Rahaivondrafahitra B, et al. Family, social and cultural determinants of long-lasting insecticidal net (LLIN) use in Madagascar: secondary analysis of three qualitative studies focused on children aged 5–15 years. Malar J. 2021;20:168.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Dhangadamajhi G, Ranjit MR. High prevalence and gender bias in distribution of Plasmodium malariae infection in central east-coast India. Trop Biomed. 2009;26:326–33.

    CAS  PubMed  Google Scholar 

  37. Steenkeste N, Rogers WO, Okell L, Jeanne I, Incardona S, Duval L, et al. Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination. Malar J. 2010;9:108.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Ototo EN, Mbugi JP, Wanjala CL, Zhou G, Githeko AK, Yan G. Surveillance of malaria vector population density and biting behaviour in western Kenya. Malar J. 2015;14:244.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Doumbe-Belisse P, Ngadjeu CS, Sonhafouo-Chiana N, Talipouo A, Djamouko-Djonkam L, Kopya E, et al. High malaria transmission sustained by Anopheles gambiae sl occurring both indoors and outdoors in the city of Yaoundé. Cameroon Wellcome Open Res. 2018;3:164.

    Article  PubMed  Google Scholar 

  40. Mfuh KO, Achonduh-Atijegbe OA, Bekindaka ON, Esemu LF, Mbakop CD, Gandhi K, et al. A comparison of thick-film microscopy, rapid diagnostic test, and polymerase chain reaction for accurate diagnosis of Plasmodium falciparum malaria. Malar J. 2019;18:73.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Whittaker C, Slater H, Nash R, Bousema T, Drakeley C, Ghani AC, et al. Global patterns of submicroscopic Plasmodium falciparum malaria infection: insights from a systematic review and meta-analysis of population surveys. Lancet Microbe. 2021;2:e366–74.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Gerardin J, Ouédraogo AL, McCarthy KA, Eckhoff PA, Wenger EA. Characterization of the infectious reservoir of malaria with an agent-based model calibrated to age-stratified parasite densities and infectiousness. Malar J. 2015;14:231.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Gonçalves BP, Kapulu MC, Sawa P, Guelbéogo WM, Tiono AB, Grignard L, et al. Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity. Nat Commun. 2017;8:1133.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Singh US, Praharaj M, Sharma C, Das A. Paradigm shift in transmission of vector-borne diseases. Emerg Infect Dis. 2016;1:116.

    Google Scholar 

  45. Varo R, Balanza N, Mayor A, Bassat Q. Diagnosis of clinical malaria in endemic settings. Expert Rev Anti Infect. 2021;19:79–92.

    Article  CAS  Google Scholar 

Download references


The authors are grateful to all the staff of the National Malaria Control Program, Accra, Ghana and the Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana for their support.


No funding was obtained for this work.

Author information

Authors and Affiliations



LEA, KM, AA, GA and NP designed the experiment. KM funded the experiment. DD, JA, AB, DB and SA performed the experiment. KKA and LEA analysed the data. JA, LEA and KKA drafted the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Linda E. Amoah.

Ethics declarations

Ethics approval and consent to participate

Ethical approval was obtained from the Institutional Review Board of the Noguchi Memorial Institute for Medical Research (NMIMR) CPN 068/17–18. Written informed consent was also obtained from each participant, including consent for children aged between 12 and 17 years and parental consent for all children aged ≤ 17 years, before recruitment and sampling.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Figure S1.

Representative gel images of products from the different Plasmodium speciation reactions.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amoah, L.E., Asare, K.K., Dickson, D. et al. Nationwide molecular surveillance of three Plasmodium species harboured by symptomatic malaria patients living in Ghana. Parasites Vectors 15, 40 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: